| Ditemukan 808 dokumen dengan kata kunci 6177 |
Simpan CSV  |
|
Validation of endogenous control reference genes for normalizing gene expression studies in endometrial carcinoma
|
| No. Panggil: MHR Basic science of reproductive medicine; Volume 21, No.9, September 2015: p.723–735 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Validation of endogenous normalizing genes for expression analyses in adult human testis and germ cell neoplasms
|
| No. Panggil: MHR Basic science of reproductive medicine; Volume 20, No.8, August 2014: p.709–718 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD
|
|
|
|
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis
|
|
|
|
Gene expression in human ovarian tissue after xenografting
|
| No. Panggil: MHR Basic science of reproductive medicine; Volume 20, No.6, June 2014: p.514–525 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy
|
|
|
|
Human epidermal growth factor receptor-2-positive breast cancer: does estrogen receptor status define two distinct subtypes?
|
|
|
|
Homeobox gene transforming growth factor b-induced factor-1 (TGIF-1) is a regulator of villous trophoblast differentiation and its expression is increased in human idiopathic fetal growth restriction
|
| No. Panggil: MHR Basic science of reproductive medicine; Volume 19, No.10, October 2013: p.665–675 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck†
|
|
|
|
A randomized phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab versus carboplatin-based therapy alone in patients with relapsed, platinum-sensitive ovarian cancer
|
|
|
Hasil Pencarian
